Rebecca L. Haffajee, JD, MPH; Anupam B. Jena, MD, PhD; Scott G. Weiner, MD, MPH
has audio
JAMA. 2015;313(9):891-892. doi:10.1001/jama.2014.18514
This Viewpoint describes the benefits of, evidence behind, and prescriber concerns with mandates, and recommends policies that may increase effective use of prescription drug monitoring programs.
-
Podcast:
Mandatory Use of Prescription Drug Monitoring Programs
John J. Marini, MD; Jean-Louis Vincent, MD, PhD; Djillali Annane, MD
JAMA. 2015;313(9):893-894. doi:10.1001/jama.2014.18484
This Viewpoint discusses new challenges and opportunities related to the care of critically ill patients.
Scott Y. H. Kim, MD, PhD; Franklin G. Miller, PhD
JAMA. 2015;313(9):895-896. doi:10.1001/jama.2014.18528
This Viewpoint debates the guidance on ethics for studies that compare interventions within established standards of care.
Ravi Rajaram, MD; Cynthia Barnard, MBA; Karl Y. Bilimoria, MD, MS
JAMA. 2015;313(9):897-898. doi:10.1001/jama.2015.52
This Viewpoint discusses how the Center for Medicare and Medicaid鈥檚 use of Patient Safety Indicator-90 in pay-for-performance programs falls short in its attempt to accurately and fairly measure patient harm.